STAT3 and T-cell large granular lymphocyte leukemia: The 10-year OS rate in our cohort of patients was 78% without differences when we analyzed it according to the WHO diagnosis (T-LGLL vs. CLPD-NK) or STAT3 mutational status, in agreement with other published data [13,15].